| 词条 | Climacteron |
| 释义 |
| image = | width = | caption = | image2 = | width2 = | caption2 = | type = combo | drug_name = Climacteron | component1 = Estradiol benzoate | class1 = Estrogen | component2 = Estradiol dienanthate | class2 = Estrogen | component3 = Testosterone enanthate benzilic acid hydrazone | class3 = Androgen/anabolic steroid | tradename = Climacteron | Drugs.com = | MedlinePlus = | licence_EU = | licence_US = | DailyMedID = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = Intramuscular injection | CAS_number = 8063-58-9 | CAS_supplemental = | ATCvet = | ATC_prefix = | ATC_suffix = | ATC_supplemental = | PubChem = 9577491 | PubChemSubstance = | IUPHAR_ligand = | DrugBank = | ChemSpiderID = | UNII = | KEGG = | ChEBI = | ChEMBL = | synonyms = }}Climacteron is a combination formulation of 1.0 mg estradiol benzoate, 7.5 mg estradiol dienanthate, and 150 mg testosterone enanthate benzilic acid hydrazone (69 mg testosterone base) which is used in the treatment of menopausal symptoms in postmenopausal women.[1][2] It is administered by intramuscular injection and is given once every 4 to 8 weeks or less frequently.[1] See also
References1. ^1 https://www.drugs.com/mmx/climacteron.html {{Androgens and antiandrogens}}{{Estrogens and antiestrogens}}{{Steroid-stub}}{{Genito-urinary-drug-stub}}2. ^{{cite journal | vauthors = Sherwin BB | title = Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women | journal = Psychoneuroendocrinology | volume = 13 | issue = 4 | pages = 345–57 | date = 1988 | pmid = 3067252 | doi = 10.1016/0306-4530(88)90060-1 | url = }} 6 : Androgens and anabolic steroids|Combination drugs|Estradiol esters|Prodrugs|Synthetic estrogens|Testosterone esters |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。